Mattiucci, Gian Carlo
 Distribuzione geografica
Continente #
EU - Europa 4.815
NA - Nord America 4.812
AS - Asia 1.957
SA - Sud America 406
AF - Africa 48
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 12.065
Nazione #
US - Stati Uniti d'America 4.743
DE - Germania 1.875
SE - Svezia 954
CN - Cina 690
SG - Singapore 684
IT - Italia 446
BR - Brasile 368
UA - Ucraina 327
FR - Francia 326
IE - Irlanda 220
IN - India 196
GB - Regno Unito 172
ID - Indonesia 135
FI - Finlandia 120
RU - Federazione Russa 89
TR - Turchia 82
PL - Polonia 63
BE - Belgio 61
CA - Canada 48
CZ - Repubblica Ceca 35
CI - Costa d'Avorio 33
NL - Olanda 31
IR - Iran 30
AT - Austria 24
VN - Vietnam 23
JP - Giappone 22
AU - Australia 12
HK - Hong Kong 12
KR - Corea 12
CH - Svizzera 11
IQ - Iraq 11
MX - Messico 10
AR - Argentina 9
AZ - Azerbaigian 9
EU - Europa 9
LT - Lituania 9
EC - Ecuador 8
BD - Bangladesh 7
ES - Italia 7
NO - Norvegia 7
RO - Romania 7
CL - Cile 6
LU - Lussemburgo 6
VE - Venezuela 6
ZA - Sudafrica 6
KZ - Kazakistan 5
PT - Portogallo 5
SA - Arabia Saudita 5
AM - Armenia 4
LK - Sri Lanka 4
AL - Albania 3
CO - Colombia 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BZ - Belize 2
HU - Ungheria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 12.064
Città #
Chandler 1.081
Singapore 425
Ashburn 394
Jacksonville 227
Dublin 220
Ann Arbor 216
San Mateo 202
Dearborn 145
New York 142
Nanjing 137
Jakarta 133
Wilmington 131
Woodbridge 117
Boston 109
The Dalles 97
Milan 94
Nürnberg 92
Los Angeles 83
Beijing 80
Munich 75
Marseille 72
Princeton 69
Bremen 67
Izmir 65
Brussels 61
Fairfield 60
Cattolica 59
Frankfurt am Main 55
Lawrence 55
Hyderabad 54
Moscow 51
Warsaw 50
Seattle 47
Nanchang 45
Rome 44
Helsinki 43
Redwood City 43
Houston 39
Abidjan 33
São Paulo 33
Zhengzhou 33
Detroit 30
Shenyang 29
Boardman 28
Kunming 28
Redmond 28
Jiaxing 27
Leawood 27
Nuremberg 23
Cambridge 21
Norwalk 21
Augusta 20
Changsha 20
London 20
Tianjin 20
Hebei 18
Toronto 18
Hefei 17
Ottawa 17
Pune 17
Düsseldorf 16
Shanghai 15
University Park 12
Bexley 11
Chicago 11
Fremont 11
Hangzhou 11
Hong Kong 11
Lauterbourg 11
Mountain View 11
Seoul 11
Vienna 11
Washington 11
Amsterdam 10
Ardabil 10
Auburn Hills 10
Portsmouth 10
Tokyo 10
Turku 10
Xi'an 10
Baku 9
Belo Horizonte 9
Bologna 9
Brno 9
Falls Church 9
Monmouth Junction 9
Andover 8
Berlin 8
Guangzhou 8
Jinan 8
Ningbo 8
North Bergen 8
Roubaix 8
San Diego 8
San Francisco 8
Bari 7
Hanoi 7
Kish 7
Lanzhou 7
Paris 7
Totale 6.091
Nome #
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 218
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 187
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 185
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 181
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 179
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 176
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 157
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 157
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 156
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 155
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 151
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 149
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 149
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 148
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 147
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 144
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 143
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 143
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 141
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 140
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 139
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 139
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 136
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 135
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 134
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 125
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 124
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 124
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 124
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 124
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 122
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 122
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 121
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 119
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 117
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 116
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 113
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 112
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 111
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 110
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 110
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 109
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 109
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 109
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 108
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 107
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 106
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 106
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 104
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 104
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 103
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 101
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 99
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 98
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 96
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 94
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 90
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 90
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 90
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 88
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 87
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 86
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 86
Can automation in radiotherapy reduce costs? 85
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 85
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 84
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 83
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 82
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 82
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 81
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 81
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 79
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 78
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 78
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 77
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 76
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 76
In reply to Yamazaki et al 75
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 75
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 73
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 72
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 72
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 71
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 71
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 71
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 69
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 69
Prostheses irradiation in high risk breast cancer patients: clinical and aesthetic outcomes in retrospective series 69
New standards for the management of nose vestibule malignancies 68
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 68
Radiation therapy for prostate cancer: What's the best in 2021 67
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 66
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 66
The impact of radiomics in diagnosis and staging of pancreatic cancer 64
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 64
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 61
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 61
Robotic radiosurgery in pancreatic cancer: A systematic review 60
776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER 60
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 59
Totale 10.631
Categoria #
all - tutte 52.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 0 0 0 0 0 0 81
2020/2021793 42 86 16 87 125 46 64 20 107 52 133 15
2021/20221.261 121 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/20252.423 58 87 176 95 270 83 77 130 394 268 508 277
Totale 12.237